Table 9.
Day | K1-70™ dose (mg/kg/dose) | Sex | Cmax (µg/mL) | tmax (h) | AUC(0–t) (µg h/mL) |
---|---|---|---|---|---|
1 | 10 | M | 275 | 0.6 | 27,000 |
F | 348 | 0.6 | 28,900 | ||
30 | M | 1090 | 0.6 | 97,500 | |
F | 1000 | 0.6 | 93,800 | ||
100 | M | 2820 | 0.6 | 254,000 | |
F | 3180 | 0.6 | 268,000 | ||
22 | 10 | M | 688 | 0.6 | 64,100 |
F | 597 | 8.5 | 66,900 | ||
30 | M | 1910 | 0.6 | 195,000 | |
F | 1710 | 8.5 | 173,000 | ||
100 | M | 5610 | 0.6 | 595,000 | |
F | 5560 | 0.6 | 592,000 |
The level of K1-70™ in serum was measured using the PK ELISA from RSR Ltd
AUC(0–t) area under the concentration–time curve over the interval 0 to t, where t is the time of the last measurable concentration, Cmax maximum serum concentration, F female, M male, t 168 h, tmax time to maximum serum concentration